Ondansetrom Baxter (Ondansetron)

Ondansetron, the active ingredient in Ondansetrom Baxter, is a 5-HT3 receptor antagonist presented as a unknown/unknown for oral use. It treats and prevents nausea and vomiting associated with chemotherapy, radiotherapy, and surgery. GNH USA supplies Ondansetrom Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Ondansetrom Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving ... worldwide.

Ondansetron acts as a selective serotonin 5‑HT3 receptor antagonist that helps the treatment of nausea and vomiting.

- Chemotherapy‑induced nausea and vomiting: It the … … … … … … ... .... .... ... ... ...